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ABSTRACT
Chitosan-impregnated gutta-percha points (ChitGPP) were tested for their ability to inhibit the
growth of microorganisms usually involved in root canal infections. Their mechanical properties
were also studied and compared with the commonly used commercial points in endodontics.
ChitGPP were more efficient in reducing the microbial load than those without chitosan. ChitGPP
also possess better tensile and elastic properties than commercial ones. After six months of stor-
age, ChitGPP’s were still able to reduce the bacterial load by 1 log, suggesting that impregnation
of gutta-percha points with chitosan could be a good alternative to obtain gutta-percha points
with improved antimicrobial properties.
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Microorganisms are the major etiological agents in pulpal
and periapical disease. In case of primary endodontic infec-
tions the main etiological agents consists mainly of strict
anaerobes. However, in cases of failed endodontic treatment,
the intracanal microflora is altered and facultative anaerobes
predominate[1,2]. The efficient control and elimination of
microorganisms are very important during endodontic treat-
ment because of their role in these diseases. Biomechanical
preparation of infected root canals using chemical substances
with antimicrobial activity can eliminate most of the micro-
organisms present, although some may remain in the root
canal system, dentinal tubules or apical resorption craters,
thus forming an apical bacterial biofilm. In these cases,
intracanal medication is necessary to completely eliminate
them[3,4]. Thus, two of the main goals of the endodontic
therapy are the elimination of microorganisms from the root
canal system and the prevention of subsequent reinfection[5].
For this purpose, gutta-percha cones are the most universally
accepted filling material due to their desirable properties
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such as biological compatibility, pliability, dimensional sta-
bility, radiopacity, and easy removal from the canal when
required. Evidence of slight antibacterial activity for gutta-
percha cones exists and it is known to be due to the zinc
oxide (ZnO), the major component of the cones[6].
However, the effect is too weak and limited for this mater-
ial to be an effective antimicrobial agent. Otherwise, most
currently used root canal filling materials do not possess a
complete seal, which may contribute to treatment failures
via re-colonization by bacteria and recontamination of the
canal system. Enterococcus faecalis has been classified as
one of the most resistant oral pathogens, especially in sec-
ondary and persistent root canal infections[7]. Anaerobic
species such as Peptostreptococcus micros, Porphyromonas
gingivalis, Porphyromonas endodontalis, Prevotella interme-
dia, and Prevotella nigrescens have also been found in teeth
with failing endodontic treatment[8]. On the other hand,
Candida albicans has been the fungal species most often
detected in these infections[9].
Different compositions of gutta-percha cones have been
previously studied by several authors: although calcium
hydroxide (Ca(OH)2) and ZnO are widely recognized in the
dental practice as the antimicrobials of choice, Ca(OH)2, ZnO/
chlorhexidine, or ZnO/iodine-polyvinyl-pyrrolidone-
containing gutta-percha cones failed to effectively inhibit
endodontic pathogens in root canals[10]. In other studies,
gutta-percha cones containing chlorhexidine presented anti-
microbial activity whereas gutta-percha cones containing
Ca(OH)2 did not
[11]. Similar results were attained in the
studies by Decurcio et al.[12] and €Oztan et al.[13]. The latter
revealed that gutta-percha points containing a mixture of
Ca(OH)2 and chlorhexidine diacetate have higher efficacies
than Ca(OH)2 or chlorhexidine diacetate alone against C. albi-
cans, C. tropicalis, and Saccharomyces cerevisiae. According to
Vijay et al.[14], tetracycline-impregnated gutta-percha offers
maximum antibacterial advantage over Ca(OH)2 and trad-
itional gutta-percha against E. faecalis. Shur et al.[15] showed
that iodoform-containing gutta-percha cones had an in vitro
inhibitory effect against S. aureus and Fusobacterium
nucleatum but not against E. faecalis, E.coli and
Pseudomonas aeruginosa.
Chitosan, a natural and non-toxic polymer, is produced
by the deacetylation of chitin and has received considerable
attention in a wide range of applications due to their bio-
logical (anti-microbial, bio-adhesive, bio-compatible, and
binding agent) properties[16]. Applications of the antimicro-
bial activity of chitosan are currently investigated in food,
textile, and cosmetic industries and in medicine, including
dentistry[17–21]. In addition, natural bioactive materials have
recently been investigated as promising agents to prevent
oral diseases such as dental caries. Chitosan showed antibac-
terial properties against oral bacterial pathogens[22–25].
Furthermore, recent studies demonstrated that water-soluble
reduced chitosan, used as a mouth rinse solution, displayed
an antibacterial and plaque-reducing action[26–29]. Chewing
gum containing chitosan and chitosan derivatives, also
effectively inhibited the growth of cariogenic bacteria in sal-
iva[30–32]. Chitosan nanoparticles were also tested for the
loading of toothpaste bioactive compounds and adhesion on
tooth analogs. Results showed that chitosan has a great
potential to be used for the in situ release of the active com-
pounds in a sustained manner[33,34].
These advantages and applications of chitosan suggest its
potential usage in root canal treatment and some authors
have already carried out some preliminary assays in this
field. Ahmed et al.[35] developed chitosan films containing
ciprofloxacin and diclofenac sodium for the topical treat-
ment of periodontitis. However, in these studies chitosan
was used as release material and not as the active ingredient.
Moreover recently, DaSilva et al.[36] and Carpio-Perochena
et al.[37] have reported the use of chitosan nanoparticles to
inhibit biofilm formation and as an antibacterial agent when
combined with root canal sealers. In this study, chitosan was
directly used to impregnate gutta-percha cones and the anti-
microbial and mechanical properties of Chitosan-impreg-
nated gutta-percha points (ChitGPP) were demonstrated
and compared with that of commercial available ones.
2. Materials and methods
2.1. Microorganisms
Gram-negative (Prevotella buccae CCUG 15401 (Culture
Collection University of G€oteborg, Sweden)), Porphyromonas
gingivalis (generously donated by Dr. Cristina Pina,
Universidade Fernando Pessoa), Gram-positive strict anae-
robes (Peptostreptococcus stomatis CCUG 51858), a Gram-
positive facultative anaerobic bacteria (Enterococcus faecalis,
from our culture collection), and a yeast (Candida albicans
ATCC 18804), were used in the present study. All obligate
anaerobic bacteria were grown in Wilkins-Chalgren agar
(WC agar, Oxoid, Basingstoke, UK), E. faecalis was grown in
M17 agar (Difco, Detroit, MI) and C. albicans was grown in
potato dextrose agar (PDA, Lab M, Bury, UK). All bacterial
strains were cultured at 37 C, whereas only C. albicans was
cultured at 30 C. Anaerobes were incubated under anaer-
obic atmosphere in a GasPak jar (Becton-Dickinson,
Heidelberg, Germany).
2.2. Gutta-percha points and chitosan
For the experiments, ISO 20 and IS0 60-sized gutta-percha
points (Dentsply, UK) were used. Composition was previ-
ously described by Gurgel-Filho et al.[38] as follows: 14.5%
(w/w) gutta-percha, 1.2% (w/w) resin, 28.0% (w/w) metal
sulphates, 2.8% (w/w) zinc chloride, and 56.3% (w/w) ZnO.
Chitosan (Low molecular weight (LMW), Sigma-Aldrich,
St. Louis, MO) were used to impregnate the commercial
gutta-percha points. To carry out the coating, a chitosan
solution was prepared as follows: chitosan (1.4–2%) was
dissolved in 1% acetic acid (v/v) and mixed with a plasti-
cizer, specifically with 40% (v/v) of sorbitol solution. Then,
the pH was adjusted to 5.8 to ensure that the antimicrobial
effect caused by chitosan was not due to the low pH or the
acid effect brought about by the acetic acid solution. The
mixture was placed in a petri plate and were dried at
37 C until a dense solution was obtained, which was then
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used to coat the commercial gutta-percha points. After
manual coating, the points were left to dry to obtain a film
around the gutta-percha points and were stored in the dark
until further analysis. The film was prepared as aforemen-
tioned, after drying, 0.14, 0.20, and 0.40mg of chitosan sur-
rounding the gutta-percha points were obtained. These
were weighed before and after impregnation.
2.3. Antimicrobial activity
The antimicrobial activity of gutta-percha points impregnated
with chitosan was evaluated by determining the inhibition of
microbial growth using a modified method developed by
Podbielski et al.[10] For this purpose, experimental inoculum
of the different microorganisms (P. buccae, P. gingivalis, P.
stomatis, E. faecalis, and C. albicans) were obtained after over-
night growth (ca. 107 CFU/mL) at 37 C in the appropriate
growth conditions. Cells were then harvested by centrifuga-
tion at 2000 g for 10min and re-suspended in the same vol-
ume of sterile 0.9% sodium chloride (NaCl) solution. Aliquots
(100 mL) were then added to sterile 0.2mL Eppendorf tubes
containing three pieces of ChitGPP, previously cut and steri-
lized under ultraviolet light. Eppendorf tubes containing only
microbial suspensions served as controls and different tubes
were used for each sampling time. Un-impregnated gutta-
percha points (GPP) were also evaluated in the same way
than those impregnated with chitosan. In order to avoid
contaminations, separate tubes containing ChitGPP and
GPP as well as controls were used for each sampling time.
The tubes were maintained at 37 C and under aerobic or
anaerobic conditions (GasPak, Heidelberg, Germany)
according to the microorganism. The antimicrobial assay
was carried out with E. faecalis and ISO 60-sized gutta-per-
cha points impregnated with a solution containing 0.14mg
of chitosan during 48 h and sampled at 0, 1, 3, 5, 7, 18, 24,
and 48 h. Later, different amounts of chitosan (0.14, 0.2,
and 0.4mg) contained in the ISO 60 sized ChitGPP were
tested against E. faecalis in 24 h assays to evaluate the effect
of the amount of chitosan.
The assays were repeated for P. buccae, P. gingivalis P.
stomatis, and C. albicans, using the ISO 60 sized
gutta-percha points impregnated with 0.4mg of chitosan
during 24 h and sampled at 0, 3, 7, and 24 h. The reinfection
event was simulated, by inoculation with 109 CFU/mL to
attain a final concentration of 107 CFU/mL. Samples were
taken at 0, 3, 7, and 24 h after re-infection. When the tubes
were removed at each sampling time, they were vortexed for
15 s and aliquots (10 mL) of the bacterial suspensions were
serially diluted in 90 lL sterile 0.9% NaCl solution. Aliquots
(20 lL) of each dilution were plated onto the aforementioned
solid medium depending of the microorganism. After incu-
bation at 37 C for 48 h, colonies were enumerated and
CFU/mL of suspension were calculated. Each experiment
was performed in duplicate and on two independent
experiments.
Efficacy of gutta-percha points after storage period was
also evaluated. Thus antimicrobial activity of GPP and ISO
60-sized ChitGPP (0.14mg LMWC) was evaluated against
E. faecalis after 0, 1, 3, and 6 months of storage.
Antimicrobial activity was evaluated as aforementioned
after 7 h of infection (at the time of maximum effect of chi-
tosan). All assays were carried out in triplicate.
2.4. Mechanical properties
ChitGPP and GPP were subjected to tensile tests using a
Universal Testing machine (model 4501, Instron
Corporation, Canton, MA) equipped with fixed grips and a
5 kN-static load cell operated according to the reference
method[39]. The initial grip separation was set at 50mm and
the crosshead speed was fixed at 4.8mm/min. Tensile
strength, elongation at break, and Young’s modulus were
determined in 18 independent cones using the Series IX
Automated Materials Testing System software, v. 809.00
(Instron Corporation). In addition, the maximum force
required to bend the ChitGPP and GPP to a 20-degree angle
at a test diameter of 10mm was recorded in 15 independent
cones using a L&W bending tester (Lorentzen & Wettre,
Kista, Sweden).
2.5. Statistical analysis
Statistical analyses were performed using SPSS v.24 software
(SPSS, Chicago, IL) via one-way analysis of variance. The
viable numbers of microorganisms/mL were transformed
into the log10 of the CFU/mL. Differences obtained at the
p< .05 level were considered to be significant.
3. Results
3.1. Antimicrobial activity
Enterococcus faecalis was the selected microorganism to
determine the best concentration to be used in impregna-
tion, because it is a prevailing microorganism in the oral
cavity and one which is very resistant to antimicrobials,
besides sometimes is the only isolated microorganism from
the oral cavity[40]. The first study encompassing the anti-
microbial activity of ISO20 sized ChitGPP against E. faecalis
was carried out for 14 days to evaluate the antimicrobial effi-
cacy (0.14mg of chitosan was used for impregnation). The
results obtained (data not shown) indicated that, after 8 h
the ChitGPP caused an important reduction (5 log-units) on
bacterial cells in comparison with the control that showed
an increase of bacterial cells of almost 3 log-units whereas
and the un-impregnated gutta-percha points showed an
increase of 0.5 log-units. After that, no significant reduction
was observed with the bacterial counts remaining at ca.
2 107 CFU/mL. After eight hours, bacterial counts in GPP
slightly increased reaching ca. 11 log-units and after one day
this value decreased down to 8 log-units and only after two
days it reached the minimum value of 5 log-units (below
that reached by ChitGPP). By three days, the viable cell
numbers obtained for the three conditions reached the same
value (6.5 log), suggesting cell death under the conditions
reported here.
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Although the antimicrobial effect of ISO 20-sized
ChitGPP during the first 48 h of contact was clearly demon-
strated, it was evident that the thin surface of the used
gutta-percha point could only support on its surface a lim-
ited amount of chitosan (0.14mg), assuming the maximum
dissolved concentration of 2%. This amount induced a rapid
reduction of 5 log CFU/mL in the first 8 h so, it was inter-
esting to evaluate if increasing the total gutta-percha surface
would promote higher and faster antimicrobial effect. Hence,
a new experiment was developed with ISO 60-sized points to
establish the improved antimicrobial efficiency with the
increased impregnation area. Additionally, it should be
noted that these points are the basis to seal the root canal,
since the technique implies the introduction in the first place
of a major gutta-percha point more representative of the fill-
ing area and then filling the canal with those with a smaller
size just to completely seal the spaces usually associated with
cements. The results are featured in Figure 1; the treatment
differences were all statistically significant (p< 0.05). The
number of viable cells increased in the assays where gutta-
percha points were not included, starting to decrease after
seven hours of inoculation. In the experiments where GPP
were included, a lower value of bacterial cells was observed
in comparison with control indicating that E. faecalis growth
was inhibited in the presence of commercial gutta-percha
points, remaining constant along the experiment with a
value of ca. 6.5 log-units. In view of these results (14 days/
ISO 20-sized gutta-percha points and 48 h/ISO 60-sized
gutta-percha points), another experiment was conducted
using the bigger sized gutta-percha points and timed experi-
ments of 24 hours, since this is the period where major
reductions were observed. It is well known that re-infection
of root canal is a frequent problem in dentistry and for that,
the use of materials that could prevent this reinfection, is
very important. Thus, to simulate a re-infection in the root
canal, the 24 h samples from the first experiment were ino-
culated in order to attain a bacterial concentration of ca. 6–7
log-units. Different amounts of chitosan (0, 0.14, 0.2, and
0.4mg) included in the film covering the point were tested
(Figure 2). Chitosan impregnated gutta-percha points
showed higher antimicrobial activity than commercial ones;
the antimicrobial activity increased with the amount of chi-
tosan used for the impregnation and impregnated gutta-per-
cha points with 0.4mg of chitosan showed a microbial
reduction of 6 log-units during the first 24 h of the assay.
After reinfection, no significant differences (p> 0.05) were
found between GPP and ChitGPP with 0.14 and 0.2mg of
chitosan. However, Gutta-percha points with 0.4mg of chi-
tosan showed, significant differences (p< 0.05) and contin-
ued to show antimicrobial activity especially after 24 h of
reinfection.
In view of this, points with 0.4mg of chitosan were
selected as displaying the best amount for the impregnation
and similar assays were carried out with P. buccae, P. gingi-
valis, and P. stomatis and as well with the yeast C. albicans,
which usually causes infection in the root canal. Figure 3a
shows the results obtained for P. buccae. In this case,
results obtained from the assays with ChitGPP, GPP and
the control were statistically different (except at 7 h were
the differences between GPP and ChitGPP were not signifi-
cant). An important reduction (5 log-units) of the num-
bers of P. buccae was found for GPP and ChitGPP after
24 h after inoculation, contrasting with almost no decrease
for the control. After reinfection, differences between
ChitGPP and GPP were more accentuated and significantly
different (p< 0.05) with ChitGPP showing greater effective-
ness than commercial points.
During the in vitro antimicrobial assays carried out
against P. gingivalis (Figure 3b), GPP only started to show
activity after 7 h of contact with the bacteria, however the
difference with respect to the control was not significant
(p> 0.05). In contrast, ChitGPP showed to be active imme-
diately after infection. After 7 h, a reduction of 7 log-units in
the bacterial counts was achieved. After reinfection, both
types of gutta-percha points, (ChitGPP and GPP) showed a
similar pattern in bacterial reduction for P. gingivalis with
no significant differences between the two treatments.
Results obtained for P. stomatis (Figure 3c), showed a
noticeable antimicrobial activity of ChitGPP; a 3 log-unit
reduction was obtained during the first 7 h of infection and
6 logs after 24 h. GPP only showed a slight decrease in
Figure 2. Antimicrobial activity of ISO 60 sized impregnated gutta-percha
points with different amounts of LMWC (0.14, 0.20, and 0.40mg) upon contact
with E. faecalis during 48 h. Reinfection was applied 24h after the first infection.
Vertical bars represent standard deviation (n¼ 4).
Figure 1. Antimicrobial activity of ISO 60 sized chitosan-impregnated gutta-per-
cha points with 0.14mg of LMWC upon contact with E. faecalis during 48 h.
Vertical bars represent standard deviation (n¼ 4).
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bacterial counts. After reinfection ChitGPP maintained its
antimicrobial activity (p< 0.05) and a 5 log-unit reduction
in the bacterial counts was achieved by 30 h.
Figure 3d shows the antifungal in vitro assays carried out
with C. albicans and ChitGPP with 0.4mg of chitosan.
Results showed a significant decrease throughout time, up to
27 h on fungal survival with respect to the assays done with
non-impregnated points. However, by 48 h no significant
differences were found when compared to the control.
Maximum reduction was obtained seven hours after impreg-
nation and only a 2 log-unit reduction was achieved.
3.2. Effect of storage in the antimicrobial activity
of chitosan impregnated gutta-percha points
The effect of the storage on the antimicrobial activity of ISO
60-sized ChitGPP and GPP against E. faecalis was also eval-
uated. Figure 4 shows the results obtained for 0, 1, and 6
months of storage, respectively. ChitGPP (non-stored),
showed to possess a reduction capacity on the bacterial
charge of ca. 3.5 log-units whereas GPP did not show a sig-
nificant decrease of the viable cell numbers. After 1 month
of storage, ChitGPP was able to reduce the microbial load
by only 2 logs with respect to the control. However, GPP
showed a slight increase in its capacity to reduce the micro-
bial load and showed a reduction of 0.5 logs with respect to
the control, perhaps due to liberation of ZnO upon storage
(p< 0.05). After six months, the ChitGPP was able to reduce
the bacterial load by 1 log, whereas GPP maintained its
reduction capacity at 0.5 logs (p< 0.05). These results sug-
gest that partial degradation of gutta-percha points might be
occurring[41] or in the film surrounding the gutta-percha
points[42] and probably other assays should be carried out to
confirm this. Despite this, results were always better than
those obtained for commercial points.
3.3. Mechanical properties
The main mechanical properties (tensile strength, elongation,
and bending force) were evaluated to determine if chitosan
could affect these properties in commercial gutta-percha
points and, consequently, become more suitable to be used
in root canal treatments. The impregnation of commercial
gutta-percha points with chitosan provided enhanced resist-
ance to deformation/rupture. As can be observed in Table 1,
significantly higher values for tensile strength (ultimate and
yield strength) were found in ChitGPP. When ChitGPP was
placed under tensile stress they elongated more as shown by
the significantly high maximum elongation values obtained.
Thus, they retained the most ductility, a useful clinical char-
acteristic for filling materials. To examine flexural rigidity, a
bending test was conducted, although no significant differen-
ces were obtained with respect to the force required to bend
the points to a 20-degree angle. However, ChitGPP showed
statistically significant differences for elasticity when com-
pared to commercial ones. Young modulus was found to be
Figure 3. Survival of E. faecalis (a), P. buccae (b), P. gingivalis (c), P. stomatis (d), and C. albicans (e) when in contact with ISO 60 sized impregnated gutta-percha
points with 0.4mg of LMWC during 48 h. Reinfection was applied 24h after the first infection. Vertical bars represent standard deviation (n¼ 4).
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significantly higher for GPP than for ChitGPP, indicating




The first screening encompassing the antimicrobial activity of
ISO 20-sized ChitGPP were carried out against E. faecalis, the
microorganism were most frequently found in endodontic
infections, especially in secondary and persistent root canal
infections[43]. The fact that GPP showed a higher antimicrobial
activity than ChitGPP can be due to the partial dissolution of
the components of the ISO 20-sized gutta-percha points with
antimicrobial activity such as ZnO. This is apparent, once the
effect is not immediate as for chitosan, since ZnO requires a
certain time to get dissolved, explaining the absence of effect
until 8 h and the increasing inhibition effect from 8h onwards.
The ISO 20-sized points are very thin and the contact with
the saline solution during the experiment allowed the release
of such components, a scenario that could also occur in vivo
conditions in the root canal. The literature reports that,
although added to gutta-percha points primarily for mechan-
ical stability reasons, ZnO alone possesses antimicrobial activ-
ity, thus decreasing bacterial counts[44]. Antimicrobial activity
of ZnO alone was described for some endodontal pathogens
such as P. micros, Veillonella parvula, Prevotella melaninogen-
ica, Streptococcus mutans, and P. aeruginosa, a result similar to
that found in this study. This effect can be attributed to the
toxicity of the metal ion Zn2þ[45]. In the case of ChitGPP, the
film around the point could be acting as a protective barrier
thus hindering the liberation of ZnO, but assuring the anti-
microbial effect through chitosan. As a result, the preliminary
screening showed a fast bactericidal effect (reductions higher
than 3 log cycles) in less than 8h. Results obtained with
ChitGPP were similar to those obtained by Podbielski et al. [46]
with the other gutta-percha points containing Ca(OH)2, a mix-
ture of ZnO and chlorhexidine (ZnO/CHX), iodine-poly-
vinylpyrrolidone (ZnO/I-PVP), or a mixture of CHX and
I-PVP and ZnO (ZnO/CHX/I-PVP). This indicates that
chitosan, incorporated in lower amounts than the other
medications provided the same antimicrobial activity
against the tested microorganisms than the other studied
gutta-percha points, thus reflecting greater efficacy.
Chlorhexidine and chitosan have the same mechanism of
antimicrobial activity, as both disrupt the bacterial cell
membrane, leading to cell death[22,47].
Candida albicans is the most common commensal and
pathological yeast found in the oral cavity[48] and, for this
reason, it was included in this study. It has been demon-
strated that Candida species are resistant to some medica-
tions commonly used in endodontics, such as Ca(OH)2.
Ferguson et al.[49] evaluated the antifungal activity of aque-
ous Ca(OH)2 and found that Ca(OH)2 was only effective as
a paste in direct contact with C. albicans. Other assays car-
ried out with saturated Ca(OH)2 solution showed that the
alkalinity of saturated Ca(OH)2 solution may not have a suf-
ficient effect on C. albicans. In addition, Ca(OH)2 solution
may readily display the Ca2þ ions necessary for the growth
and morphogenesis of Candida[50,51]. These mechanisms
may explain why Ca(OH)2 has been found to be ineffective
against C. albicans.
Chitosan however, is known to be effective against a wide
variety of fungi including C. albicans. C. albicans has shown
to be susceptible to high and LMW chitosans having MW
>32 kDa[29,52,53] and even to sub-mic concentrations of oli-
gochitosan[54], which suppressed the formation of hyphal
structures, causing severe cell wall alterations. Results
obtained by €Oztan et al.[13] showed that only the points con-
taining Ca(OH)2 and chlorhexidine were effective against the
Candida species used in their study. Specifically for C. albi-
cans results showed a total reduction after two days of incu-
bation. After 24 h, 4 log units were reduced, twice the
reduction obtained in our study with chitosan-impregnated
gutta-percha points. In comparison with bacteria, very little
is known about the ways in which fungi can circumvent the
action of antimicrobials.
4.2. Mechanical properties
The study of the mechanical properties allowed establishing
that the impregnation of gutta-percha points with chitosan
improved its mechanical properties (higher values for tensile
strength and elongation) providing enhanced resistance to
Table 1. Mean (± standard deviation) of mechanical properties of the chito-







Ultimate tensile strength, MPa 4.935 ± 0.440a 4.579 ± 0.367b
Tensile yield strength, MPa 4.712 ± 0.430a 4.466 ± 0.217b
Rupture strength, MPa 4.489 ± 0.510a 4.148 ± 0.669a
Tensile elongation, % 31.90 ± 17.89a 11.97 ± 7.727b
Yield elongation, % 14.32 ± 3.00a 5.775 ± 3.118b
Maximum elongation, % 42.97 ± 12.97a 19.49 ± 7.946b
Young modulus, MPa 65.41 ± 14.6a 160.9 ± 23.924b
Bending force, mN 0.119 ± 0.012a 0.115 ± 0.008a
a,bThe letters denote statistical significance (p< 0.05).
Figure 4. Effect of storage on ISO 60 sized chitosan (0.14mg LMW)-impreg-
nated gutta-percha points against E. faecalis in quantitative in vitro assays set
for 7 h (initial viable cell counts of 106–107 CFU/mL). (a) 0 months, (b) 1 month,
(c) 3 months, and (d) 6 months of storage at room temperature and dark condi-
tions. Vertical bars represent standard deviation (n¼ 4).
486 A. CARDELLE-COBAS ET AL.
fracture. An increase in tensile strength has been reported as a
clinically desirable characteristic so that it reflects the ability to
retrieve a snugly inserted point completely. Cones with low
percentages of gutta percha have poorer plasticity, allowing for
a poorer apical sealing as reported by Gurgel-Filho et al.[55]
Gutta percha cones also present higher elastic modulus than
other materials (e.g., Resilon)[41], which translates in less flexi-
bility under the same loading force (needing more force to
adapt to root canal walls). The lack of rigidity and adhesivity
of gutta cones have been quoted as some of the disadvantages
for its use, hindering its use in small canals. From early on,
Friedman et al.[56] reported that root canal filling material
should possess the proper combination of flexibility and rigid-
ity to permit the negotiation of almost any root canal.
Mechanical properties of individual brands were found to be a
function of the gutta-percha and ZnO concentration[57]. The
impregnation with chitosan, as reported here, seems to
improve some of the drawbacks in the mechanical properties
of gutta percha points.
5. Conclusion
From the results of the present study, it can be concluded
that chitosan impregnated gutta-percha points showed a
higher (and significant) antimicrobial and antifungal activ-
ities and improved mechanical properties when compared to
commercial gutta-percha points. The in vitro simulations of
infection in the root canal showed that chitosan impregnated
gutta-percha points were able to maintain their antimicrobial
capacity throughout time. This activity was more pro-
nounced towards P. buccae, P. stomatis, and P. gingivalis.
In brief, these results show, that the use of chitosan
impregnated gutta-percha points could be an interesting
alternative to commercial gutta-percha points. Chitosan
demonstrated an important antimicrobial effect in this appli-
cation reinforcing the action of gutta-percha points.
However, more studies including chitosan in the formulation
of gutta-percha points should be developed, especially
exploiting its action against fungi and future research needs
to be conducted to evaluate the antimicrobial efficacy of
medicated gutta-percha points under clinical conditions.
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